Nancy McCabe1, Javed Butler2, Sandra B Dunbar1, Melinda Higgins1, Carolyn Reilly3. 1. Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA, USA. 2. Cardiology Division, Stony Brook University School of Medicine, Stony Brook, NY, USA. 3. Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA, USA. Electronic address: carolyn.reilly@emory.edu.
Abstract
OBJECTIVES: To determine the relationship between 6-min walk test distance (6MWD) and 30-day readmission in hospitalized heart failure (HF) patients. BACKGROUND: 6MWD is known to predict hospitalizations in outpatients with HF, but its ability to predict recidivism in hospitalized HF patients is relatively unknown. METHODS: Seventy-one hospitalized HF patients with NYHA Class II/III (mean age 52.6 ± 12.3 years, 42.3% female, 73.2% African American) performed 6MWD prior to discharge. Logistic regression was used to determine relationships between 6MWD and 30-day readmission. RESULTS: 30-day readmission occurred in 14 (19.7%) patients. Average 6MWD was 756.4 ± 403.2 feet. Higher 6MWD significantly decreased risk of 30-day readmission, even after adjusting for sociodemographic and clinical characteristics (OR = .84, 95% CI [.71, .99]). For each additional 100 feet walked, odds of a 30-day readmission decreased by 16%. CONCLUSIONS: 6MWD predicted 30-day readmission in this study, warranting further investigation to understand how the 6MWD may predict readmissions and guide treatment in hospitalized HF patients.
OBJECTIVES: To determine the relationship between 6-min walk test distance (6MWD) and 30-day readmission in hospitalized heart failure (HF) patients. BACKGROUND: 6MWD is known to predict hospitalizations in outpatients with HF, but its ability to predict recidivism in hospitalized HF patients is relatively unknown. METHODS: Seventy-one hospitalized HF patients with NYHA Class II/III (mean age 52.6 ± 12.3 years, 42.3% female, 73.2% African American) performed 6MWD prior to discharge. Logistic regression was used to determine relationships between 6MWD and 30-day readmission. RESULTS: 30-day readmission occurred in 14 (19.7%) patients. Average 6MWD was 756.4 ± 403.2 feet. Higher 6MWD significantly decreased risk of 30-day readmission, even after adjusting for sociodemographic and clinical characteristics (OR = .84, 95% CI [.71, .99]). For each additional 100 feet walked, odds of a 30-day readmission decreased by 16%. CONCLUSIONS: 6MWD predicted 30-day readmission in this study, warranting further investigation to understand how the 6MWD may predict readmissions and guide treatment in hospitalized HF patients.
Authors: Jessica H Huston; Robinson Ferre; Peter S Pang; Ovidiu Chioncel; Javed Butler; Sean Collins Journal: Am J Ther Date: 2018 Jul/Aug Impact factor: 2.688
Authors: Iván José Fuentes-Abolafio; Brendon Stubbs; Luis Miguel Pérez-Belmonte; María Rosa Bernal-López; Ricardo Gómez-Huelgas; Antonio Ignacio Cuesta-Vargas Journal: BMC Cardiovasc Disord Date: 2020-12-09 Impact factor: 2.298
Authors: Kenji Matsumoto; Yi Xiao; Shunichi Homma; John L P Thompson; Richard Buchsbaum; Kazato Ito; Stefan D Anker; Min Qian; Marco R Di Tullio Journal: ESC Heart Fail Date: 2020-12-30
Authors: John Bisognano; John E Schneider; Shawn Davies; Robert L Ohsfeldt; Elizabeth Galle; Ivana Stojanovic; Thomas F Deering; JoAnn Lindenfeld; Michael R Zile Journal: BMC Cardiovasc Disord Date: 2021-03-26 Impact factor: 2.298